Page last updated: 2024-11-06

1,5-cod

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,5-Cyclooctadiene (1,5-COD) is a cyclic diene that is commonly used as a ligand in organometallic chemistry. It is synthesized via the dimerization of butadiene. 1,5-COD is known to form stable complexes with transition metals, such as nickel, palladium, and platinum, and these complexes are widely used as catalysts in various organic reactions, including cross-coupling reactions, polymerization, and hydrogenation. The molecule is also a versatile building block in organic synthesis. Its unique structure with two double bonds separated by a single bond allows for various reactions and modifications. The study of 1,5-COD complexes provides insight into the electronic and steric effects of ligands on metal centers, which is crucial for understanding the reactivity and selectivity of these catalytic systems. The effects of 1,5-COD can vary based on the specific application and the metal it is coordinated to. It can act as a stabilizing ligand, a reactive intermediate, or a catalyst itself, depending on the chemical environment.'

1,5-cyclooctadiene: used in production of Nylon [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID82916
MeSH IDM0367704

Synonyms (50)

Synonym
17612-50-9
(z,z)-cycloocta-1,5-diene
brn 1209288
1,5-cyclooctadiene
nsc60155
nsc-60155
cycloocta-1,5-diene
ai3-26692
einecs 203-907-1
1,5-cod
hsdb 5549
nsc 60155
(z,z)-1,5-cyclooctadiene
1,5-cyclooctadiene, (e,e)-
1,5-cyclooctadiene, (1z,5z)-
inchi=1/c8h12/c1-2-4-6-8-7-5-3-1/h1-2,7-8h,3-6h2/b2-1-,8-7
(1z,5z)-cycloocta-1,5-diene
111-78-4
1,5-cyclooctadiene, contains 50-150 ppm 4-tert-butylcatechol, 99%
1,5-cyclooctadiene, purified by redistillation, >=99%
cis,cis-1,5-cyclooctadiene, >=98.0% (gc)
AKOS000121144
NCGC00248897-01
dtxcid806888
cas-111-78-4
tox21_201015
NCGC00258568-01
1552-12-1
1e1vvd385z ,
unii-1e1vvd385z
4-05-00-00403 (beilstein handbook reference)
ec 203-907-1
cis-1,5-cyclooctadiene
BP-20393
1,5-cyclooctadiene [hsdb]
1,5-cyclooctadiene [mi]
VYXHVRARDIDEHS-QGTKBVGQSA-N
cis,cis-1,5-cyclooctadiene
W-109115
W-109416
F0001-0246
mfcd00001752
1,5-cyclooctadiene, puriss., >=99.0% (gc)
1.5-cyclooctadiene
(1z,5z)-1,5-cyclooctadiene
Q161547
AMY22290
BS-21545
EN300-658496
EN300-26087

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Since there were no other neurobehavioral findings and no toxicity findings in the 150 ppm group, the sleeping behavior in the 150 ppm group was considered insufficient evidence of an adverse effect."( Inhalation toxicity of cyclooctadiene in rats.
Bamberger, JR; Kelly, DP; Kennedy, GL; Marrs, GE; Mikles, KA, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency71.81060.000221.22318,912.5098AID1259247
histone deacetylase 9 isoform 3Homo sapiens (human)Potency50.83800.037617.082361.1927AID1259364
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (35.71)29.6817
2010's15 (53.57)24.3611
2020's3 (10.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.87 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]